BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/9/2026 7:30:47 AM | Browse: 43 | Download: 165
 |
Received |
|
2025-09-30 02:22 |
|
Peer-Review Started |
|
2025-09-30 02:22 |
|
First Decision by Editorial Office Director |
|
2025-10-17 08:37 |
|
Return for Revision |
|
2025-10-17 08:37 |
|
Revised |
|
2025-10-30 15:09 |
|
Publication Fee Transferred |
|
2025-11-06 12:24 |
|
Second Decision by Editor |
|
2025-12-15 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-15 08:31 |
|
Articles in Press |
|
2025-12-15 08:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-02 07:11 |
|
Publish the Manuscript Online |
|
2026-02-09 07:30 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Retrospective Study |
| Article Title |
Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Vijay K Trehan, Safal Safal, Siddhant Trehan, Sanjeev Kathuria and Preeti S Vani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Preeti S Vani, Medical Division, Sahajanand Laser Technology Ltd., AQ, Gandhinagar 382016, Gujarat, India. clinical@sltl.com |
| Key Words |
Drug-eluting stents; Coronary artery disease; Percutaneous coronary intervention; NeoHexa sirolimus-eluting stent; Major adverse cardiac events; Target lesion revascularization; Target vessel revascularization; Cardiac mortality |
| Core Tip |
This retrospective study provides valuable long-term real-world evidence on the safety and efficacy of the NeoHexa drug-eluting stent in an all-comer, real world patient population. Over an average follow-up of more than five years, the study observed low rates of major adverse cardiac events (4.32%), including minimal target lesion/target vessel revascularization. The findings highlight the stent’s durable performance, even in high-risk and complex patients across routine and pandemic-era clinical settings. |
| Publish Date |
2026-02-09 07:30 |
| Citation |
Trehan VK, Safal S, Trehan S, Kathuria S, Vani PS. Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy. World J Cardiol 2026; 18(2): 114636 |
| URL |
https://www.wjgnet.com/1949-8462/full/v18/i2/114636.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v18.i2.114636 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
